Know Cancer

or
forgot password

Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers


N/A
18 Years
N/A
Open (Enrolling)
Both
Head and Neck Cancer, Lung Cancer, Lip Cancer, Lip Neoplasms, Head and Neck Cancers

Thank you

Trial Information

Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers


The endpoints of the study are

1. To validate the prognostic significance of OPN in H&N and lung cancer patients and to
monitor its level during active therapy and follow up for cancer surveillance.

2. To identify a gene and protein signature for hypoxia in H&N and lung cancer patients.


Inclusion Criteria:

Newly diagnosed patients with head and neck cancer who has tumor
accessible to tumor oxygenation measurement with a microelectrode.

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Principal Investigator

Quynh-Thu Le

Investigator Role:

Principal Investigator

Investigator Affiliation:

Stanford University

Authority:

United States: Food and Drug Administration

Study ID:

ENT0016

NCT ID:

NCT00568490

Start Date:

September 1998

Completion Date:

April 2017

Related Keywords:

  • Head and Neck Cancer
  • Lung Cancer
  • Lip Cancer
  • Lip Neoplasms
  • Head and Neck Cancers
  • Neoplasms
  • Head and Neck Neoplasms
  • Lip Neoplasms
  • Lung Neoplasms
  • Anoxia

Name

Location

Stanford University School of MedicineStanford, California  94305-5317